 |
AERS Patient Outcomes by Year
as of September 30, 2008
These data describe the outcome of the patient as defined in U.S. reporting regulations (21 CFR 310.305, 314.80, 314.98, 600.80) and Forms FDA 3500 and 3500A (the MedWatch forms). Serious means that one or more of the following outcomes were documented in the report: death, hospitalization, life-threatening, disability, congenital anomaly and/or other serious outcome. Documenting one or more of these outcomes in a report does not necessarily mean that the suspect product(s) named in the report was the cause of these outcomes.
This figure illustrates the patient outcome(s) for reports in AERS since the year 1999. Serious outcomes include death, hospitalization, life-threatening, disability, congenital anomaly and/or other serious outcome. Year 2008 includes data through September.
This table represents the number of reports in AERS by patient outcome since the year 1999. Year 2008 includes data through September.
| Year |
Death |
Serious |
| 1999 |
17,399 |
153,964 |
| 2000 |
19,445 |
153,818 |
| 2001 |
23,988 |
166,384 |
| 2002 |
28,181 |
159,000 |
| 2003 |
35,173 |
177,008 |
| 2004 |
34,928 |
199,510 |
| 2005 |
40,238 |
257,604 |
| 2006 |
37,465 |
265,130 |
| 2007 |
36,834 |
273,276 |
| 2008 Q1-Q3 |
37,297 |
237,369 |
Back to Top
Back to AERS Statistics
Date created: June 6, 2008; updated January 15, 2009
|
|
